Drug profile · INN
delamanid
DELTYBA
delamanid (DELTYBA) is a mycobacterium tuberculosis h37rv inhibitor.
EMA: approved PMDA: approved Antiinfectives for systemic use (J04) J04AK06
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — delamanid
- Class
- Antiinfectives for systemic use (J04)
- Route
- —
- Patents
- 0
- Programs
- 5
- Data quality
- 0.83
Quick answer
delamanid (DELTYBA) is a mycobacterium tuberculosis h37rv inhibitor.
Key facts
INN delamanid
Brand DELTYBA
Mechanism Mycobacterium tuberculosis H37Rv inhibitor
Target Mycobacterium tuberculosis H37Rv
Therapeutic class Antiinfectives for systemic use (J04)
ATC code J04AK06
Mechanism of action
Mycobacterium tuberculosis H37Rv inhibitor
Primary target: Mycobacterium tuberculosis H37Rv
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is delamanid?
delamanid (DELTYBA) is a mycobacterium tuberculosis h37rv inhibitor.
What is the brand name for delamanid?
DELTYBA is a marketed brand name for delamanid. Check FDA Drugs@FDA for the current US label holder and prescribing information.